SYNGAP1 and epilepsy: Mutations in SYNGAP1 are implicated in intellectual disability, ASD and epilepsy and approximately 50% of patients with loss-of-function mutations in SYNGAP1 are diagnosed with ASD where tactile sensory deficits are a common feature of SYNGAP1-related ASD (Gamache et al., 2020).